HORIZON | IMMUTOL 2nd Progress Meeting
Advanced Antigen-Specific Dendritic Cells Based Therapy to Re-establish Tolerance in Immune-Mediated Diseases.
May 29, 2025
Advanced Antigen-Specific Dendritic Cells Based Therapy to Re-establish Tolerance in Immune-Mediated Diseases.
The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for the different stages of osteoarthritis. All siNPAIN partners are working hard to develop an efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.
Asphalion expert Núria García participated last week in the 2nd Annual PragmaTIL Consortium Meeting in Amsterdam, hosted
At ASPHALION we are pleased to announce our participation in RAPS EuroConvergence 2025, one of the premier
Last week, ARDAT project members gathered in Barcelona for the project’s General Assembly. The ARDAT project is
On April 3rd, Asphalion’s Montse Domingo participated in the first working session on the upcoming European Research
This project emphasizes patient engagement and involvement, ensuring that patient perspectives are integrated into the study design and execution. The focus on reducing treatment toxicity and improving quality of life is at the heart of this research, illustrating a comprehensive approach to patient care and scientific discovery.
The MISTRAL Project is an EU-funded initiative exploring the link between the gut microbiome and HIV/AIDS, specifically
Search or filter
Services
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
Memberships & PartnershipS
Quality Management System
Innovative SME
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
